Pharmacology, Toxicology and Pharmaceutical Science
Prevalence
100%
Non-Steroidal Anti-Inflammatory Drug
79%
Cohort Study
68%
Cholinergic Receptor Blocking Agent
64%
Polypharmacy
63%
Narcotic Analgesic Agent
41%
Observational Study
39%
Cross-Sectional Study
35%
Proton Pump Inhibitor
33%
Monotherapy
32%
Antiinfective Agent
32%
Comorbidity
31%
Combination Therapy
29%
Medication Error
28%
Antihypertensive Agent
28%
Anticoagulant Agent
27%
Angiotensin Receptor Antagonist
27%
Docetaxel
27%
Breast Cancer
25%
Drug Interaction
25%
Hyponatremia
25%
Analgesic Agent
22%
Antibiotics
19%
Tacrolimus
19%
Coronavirinae
19%
Non Insulin Dependent Diabetes Mellitus
19%
Beta Adrenergic Receptor Blocking Agent
17%
Drug-Drug Interaction
17%
Case-Control Study
16%
Beers Criteria
16%
Frailty
15%
Antihypertensive Therapy
15%
Chronic Kidney Failure
15%
Dexamethasone
14%
Multiple Chronic Conditions
14%
Thrombocytopenia
13%
Thiazide Diuretic Agent
13%
Taxane
12%
Cardiovascular Risk
12%
Letrozole
12%
Population Study
12%
Cancer Chemotherapy
12%
Community Pharmacy
12%
Topical Corticosteroid
12%
Musculoskeletal Disease
12%
Randomized Controlled Trial
12%
Angiotensin Receptor
12%
HIV
12%
Programmed Death 1 Ligand 1
12%
Colistimethate
12%
Medicine and Dentistry
Prevalence
51%
Nonsteroid Antiinflammatory Agent
44%
Potentially Inappropriate Medication
35%
Logistic Regression Analysis
32%
Awareness
31%
Parasympatholytic
31%
Cohort Analysis
31%
Gastrointestinal Complication
26%
Cross Sectional Study
26%
Outpatient
25%
Narcotic Analgesic Agent
25%
Hyponatremia
25%
Proton-Pump Inhibitor
21%
Medical Record
20%
Community-Dwelling Older Adults
19%
Antithrombotic
19%
Odds Ratio
16%
Elderly Patient
16%
Breast Cancer
15%
Outpatient Care
15%
Anticoagulant
15%
Polypharmacy
14%
Case-Control Study
14%
Long-Term Care
13%
Diabetes
13%
Letrozole
12%
Emergency Care
12%
Topical Corticosteroid
12%
Occupational Accident
12%
Programmed Death 1 Ligand 1
12%
Advanced Cancer
12%
Immune-Related Adverse Events
12%
Lassa Fever
12%
Patient with Type 2 Diabetes
12%
Scrub Typhus
12%
Programmed Cell Death
12%
HIV/AIDS
12%
Urogenital Tract Infection
12%
Potential Barrier
12%
Zolpidem
12%
Electronic Patient Record
12%
Sodium Glucose Cotransporter 2 Inhibitor
12%
Species Richness
12%
Retrospective Cohort Study
12%
Comorbidity
11%
Drug Interaction
11%
Major Bleeding
9%
Cardiovascular System
9%
Medication Error
9%
Sensitivity and Specificity
9%
Nursing and Health Professions
Medication Therapy Management
26%
Cohort Analysis
25%
Potentially Inappropriate Medication
24%
Logistic Regression Analysis
23%
National Health Insurance
22%
Cost Benefit Analysis
20%
Odds Ratio
19%
Meta Analysis
19%
Prevalence
16%
Outpatient Care
15%
Self Care
15%
Health Care Personnel
15%
Confidence Interval
15%
Antiinfective Agent
14%
Acute Kidney Failure
13%
Hyperlipidemia
13%
Clinical Practice
13%
Outpatient
13%
Breast Cancer
12%
Liver Graft
12%
Letrozole
12%
Economic Evaluation
12%
Medical Staff
12%
Practice Setting
12%
Occupational Accident
12%
Linezolid
12%
Waist Circumference
12%
Human immunodeficiency virus
12%
Elderly Patient
12%
Thrombocytopenia
12%
Compliance
12%
Inflammatory Arthritis
12%
Rheumatoid Arthritis
12%
Nursing Home
12%
Chemotherapy-Induced Peripheral Neuropathy
12%
Alpha Tocopherol
12%
Hyponatremia
12%
Counseling
11%
Tertiary Care Center
10%
Cross-Sectional Study
9%
Ward
9%
Polypharmacy
9%
Comorbidity
8%
Platelet Count
8%
Electronic Medical Record
8%
Supplementation
8%
Deprescribing
8%
Sensitivity and Specificity
7%
Receiver Operating Characteristic
7%
Patient Compliance
7%
